Pallas vs Mochi Health: GLP-1 Telehealth Compared

Mochi Health and Pallas Health have more in common than most GLP-1 telehealth pairings: both are weight-loss-focused platforms, both serve all 50 states, and — unusually in 2026, after most large platforms went branded-only — both still offer clinician-prescribed compounded semaglutide and tirzepatide alongside FDA-approved brands. So this comparison comes down to structure: how you pay, how care is delivered, and what happens when something changes.

This is an honest comparison. Pricing on both sides changes often; the figures here reflect each platform's published pricing as of August 2026 — confirm current numbers on both sites before signing up.

The three differences that matter most

1. Mochi charges a membership fee plus medication; Pallas is one all-in price. Mochi's membership is $79/month ($69/month with qualifying insurance, and a discounted first month where available), with medication billed separately on top — compounded semaglutide at $99/month and compounded tirzepatide at $199/month, flat at all doses per Mochi's FAQ. Pallas has no membership fee: compounded semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. Compounded tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. One number, one bill — provider care, dose adjustments, messaging, and shipping included.
2. Mochi requires a video visit to start; Pallas is asynchronous in most states. Mochi schedules your first visit with a provider as a video appointment. With Pallas, in most states there's no video visit at all — you complete the intake online, a licensed clinician reviews it, and you message your care team through the portal anytime. (A small number of states require one video visit by law; that applies to any telehealth platform serving them.)
3. The policies differ when things change. Through Pallas, if a clinician decides treatment isn't right for you, you're refunded in full, and you can cancel anytime yourself in the portal. Mochi's published terms state that prescription sales are final once sent to the pharmacy, and that cancellation is handled in the app or by phone (email requests aren't considered valid). Neither policy is hidden — but read both before you commit anywhere.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Quick comparison

What Mochi does well

It kept compounded — and priced it aggressively. Like Pallas, Mochi still offers compounded semaglutide and tirzepatide when a clinician prescribes them, and its medication-only prices ($99 and $199 a month, flat at all doses per its FAQ) are among the lowest published. Add the $79 membership and the combined monthly total for compounded semaglutide can still run somewhat below Pallas's per-month average. We'll say that plainly — if the lowest combined monthly number is your only criterion and you don't mind two separate charges, Mochi prices sharply.

Dietitian access is included. Mochi bundles registered-dietitian visits and care coaching into its membership. Pallas doesn't offer dietitian services; it's deliberately medication-first with a free tracking app instead. If structured nutrition support matters to you, that's a genuine Mochi advantage.

Insurance support on brand-name medications. For FDA-approved brands, Mochi works with your insurance (brand pricing "depends on your insurance plan") and offers a discounted membership tier with qualifying coverage. Pallas is cash-pay and doesn't route insurance today — for an insured patient set on a brand-name medication, that's worth comparing.

A physician-founded, established operation. Mochi was founded by a physician, is based in San Francisco, reports serving hundreds of thousands of members, and displays a LegitScript seal on its site. It's a real, substantial company.

What Pallas does differently

One all-in price instead of membership + medication. Pallas's compounded plans are a single number with everything included — no separate membership subscription running alongside your medication bill. Semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. Tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. The price doesn't change as your dose titrates, there's nothing to prepay to unlock a lower rate, and there's exactly one charge to track, pause, or cancel.

No video visit in most states. Mochi's care starts with a scheduled video appointment. Pallas is asynchronous-first: in most states you never book a call — complete the intake when it suits you, a clinician licensed in your state reviews it, and everything after that happens through portal messaging on your schedule. For patients who want care to fit around work and family rather than a calendar slot, this is usually the deciding difference.

Patient-friendly exit terms. If a Pallas clinician decides treatment isn't right for you, you're refunded in full. Cancellation is self-serve in the portal — no phone call required. Mochi's published terms are stricter: prescription sales are final, partial-month membership refunds aren't offered, and cancellation happens in the app or by phone.

Both tiers, with compounding as personalization. Like Mochi, Pallas offers FDA-approved Wegovy®, Ozempic®, Zepbound®, and Mounjaro® alongside compounded preparations. A clinician reaches for compounded when a brand isn't the right fit — a titration step the brand doesn't manufacture, or a per-patient formulation when clinically appropriate — not as a knockoff of the brand.

A free companion app. The Pallas companion app (Protein & GLP-1 Tracker, iOS and Android) tracks protein, steps, weight trend, and dose reminders — free, no subscription, useful whether or not you're a prescription patient.

The pricing math, honestly

For compounded semaglutide, Mochi's combined monthly total (membership + medication) typically lands somewhat below Pallas's per-month average, while first-month totals on the two platforms are roughly similar where Mochi's intro promo applies. For compounded tirzepatide, the combined totals land closer together. Pallas's number is all-in and flat; Mochi's is two separate charges, with prepay tiers that lower the membership if you commit for 3, 6, or 12 months up front.

So the honest framing isn't "one is always cheaper" — it's what you're buying with the difference: asynchronous care with no video appointment, a single all-in bill, a full refund if a clinician doesn't prescribe, and self-serve cancellation. If those matter to you, Pallas is the simpler structure. If the lowest combined monthly number plus dietitian access matters more, price Mochi carefully — including the membership, any prepay commitment, and both platforms' refund terms.

For brand-name medications, Mochi's insurance handling can win on net cost for covered patients; Pallas brand-name prescriptions are cash-pay.

Who should pick which

Mochi is probably the better fit if:

• You want the lowest combined monthly number for compounded semaglutide and don't mind membership + medication as separate charges
• You want registered-dietitian visits and coaching included
• You have insurance that covers a brand-name GLP-1 and want help using it
• You prefer starting care with a scheduled video appointment

Pallas is probably the better fit if:

• You want one flat, all-in price — no membership subscription running alongside your medication
• You want asynchronous care with no video visit in most states, and anytime provider messaging
• You want a full refund if a clinician decides treatment isn't right for you, and self-serve cancellation
• You want to manage everything yourself — orders, refills, plan switches, billing — in one portal
• You'd use a free companion app (iOS and Android) to track protein, steps, and your weight trend

Switching between them

Transitions are straightforward in either direction. Bring your medication name, current dose, and titration history (export or screenshot your records before canceling anywhere). A new provider picks up from your current dose — no restart of titration is needed unless you've been off medication for more than four weeks. For the clinical side of choosing between molecules, see semaglutide vs tirzepatide.

References

Platform pricing and program details reflect each company's publicly published terms as of August 2026 and change frequently — confirm current numbers on each platform's site before enrolling. The regulatory basis for compounded preparations is summarized by the FDA.

1. Mochi Health. Membership and medication pricing, FAQ, and terms, as published August 2026 ($79/month membership; compounded semaglutide $99/month, tirzepatide $199/month, billed separately).
2. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. 2025.

Bottom line: Mochi and Pallas are two of the few platforms still offering compounded GLP-1s alongside FDA-approved brands, and Mochi prices its medication line sharply — with a $79/month membership billed on top, a video visit to start, final-sale prescriptions, and app-or-phone cancellation. Pallas puts everything into one flat, all-in price: provider care, dose adjustments, messaging, and shipping included, asynchronous in most states, a full refund if a clinician doesn't prescribe, and self-serve everything in the portal, plus a free companion app. If the lowest combined monthly number and dietitian access win for you, price Mochi carefully; if you want the simplest, most flexible structure with no membership and no video visit, Pallas is built for exactly that.